healthcare costs
Commentary
Can Managed Access Agreements Mitigate Evidentiary, Economic and Ethical Issues with Access to Expensive Drugs for Rare Diseases in the Canadian Context?
Melanie McPhail and Tania Bubela
The Authors Respond
Expensive Drugs for Rare Diseases in Canada: Time for Action Everywhere and by Everyone
Sandra Sirrs, Helen Anderson, Bashir Jiwani, Eric Lun, Bob Nakagawa, Dean Regier, Shirin Rizzardo an...
Research Paper
Patent “Evergreening” of Medicine–Device Combination Products: A Global Perspective
Reed F. Beall, Tali Glazer, Haris Ahmad, Mikayla Buell, Slane Hahn, Adam R. Houston, Aaron S. Kessel...
Greening Healthcare
Identifying Opportunities for Greenhouse Gas Reductions and Cost Savings in Hospitals: A Knowledge Translation Tree
Myles Sergeant, Richard Webster, Linda Varangu, Anita Rao, Sujane Kandasamy, Madeline Rampton, Neha ...
Discussion and Debate
Leaving the Walkman and ICD-9 Behind: Modernizing the Disease Classification System Used by Canadian Physicians
Stephanie Garies, Phoebe Ng, James A. Dickinson, Terrence McDonald, Maeve O’Beirne, Kerry A. McBri...
Discussion and Debate
Commentary – From Mixtapes to Playlists: Evolving Options for Capturing Diagnoses in Canadian Physicians’ Data
Keith Denny
Research Paper
Building Blocks to Sustainable Rural Maternity Care: Toward a Systems Approach to Service Planning
Jude Kornelsen and Kira Koepke